Investor
3B Future Health Fund
Monaco · Monaco
Investment in early and clinical-stage healthcare startups focused on oncology and rare diseases across Europe and the US.
Stage
Seed–Series B
Sectors
Digital Health
Cheque
Up to $12m
Invests in
3 countries
Sectors
Invests in
About
This venture capital fund supports private early-stage companies in areas of high unmet patient needs. The firm concentrates on oncology and rare disease therapeutics by leveraging drug development knowledge. It invests in start-ups based in Europe, the United States, and Israel. The management team actively participates in strategic management to build value through a diversified portfolio. They typically enter at Series A or earlier stages to advance treatments from preclinical phases to the clinic.
How to approach
Submit an enquiry via the digital contact form on the website for further information from the team.
Portfolio · 4 · tap a company to read about it
Recent deals
- 2024-06iOncturaSeries B
- 2023-04Geneos TherapeuticsSeries A
- 2023-01Sibylla BiotechSeries A
- 2022-10Sibylla BiotechSeries A
- 2022-09Roca TherapeuticsSeed
- 2022-05Domain TherapeuticsSeries A
- 2022-03Kither BiotechSeries B
- 2022-03EpsilogenSeries B
- 2021-10GenEpSeed
- 2021-04GreenBoneSeries B
- 2020-07Gain TherapeuticsSeries B
- 2017-09AMAL TherapeuticsSeries B
- 2017-06GreenBoneGrowth